ABVC
ABVC Biopharma Inc
NASDAQ: ABVC · HEALTHCARE · BIOTECHNOLOGY
$1.03
-3.74% today
Updated 2026-04-29
Market cap
$26.41M
P/E ratio
—
P/S ratio
27.42x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
ABVC Biopharma Inc (ABVC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |